Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,731 GBX | -0.90% | -2.46% | +19.59% |
02:34pm | Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target | MT |
01:37pm | Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.59% | 90.55B | |
+39.78% | 731B | |
+31.54% | 586B | |
-7.50% | 348B | |
+15.98% | 319B | |
+0.35% | 273B | |
+13.53% | 235B | |
-6.67% | 203B | |
+7.54% | 202B | |
+3.29% | 159B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- LBBW Raises GSK PT, Reiterates Buy Rating